Aldeyra Allergic Conjunctivitis Drug Has Good Prospects With Phase III Results
Warming Temperatures Expand Market Potential
The company announced positive results for reproxalap from its Phase III INVIGORATE trial in allergic conjunctivitis, which may be a good sign for its dry eye disease studies.
